Indications |
Intramuscular Susceptible Gram-negative and staphylococcal infections Adult: 3 mg/kg daily in 2-3 divided doses. May also be given as IV infusion, if needed. Renal impairment: May need to adjust maintenance doses and/or dosing intervals. Topical/Cutaneous Pyoderma Adult: As 0.1% cream: Apply onto the affected area(s) bid. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Renal or liver impairment, myasthenia gravis, parkinsonism, dehydration, hypotension, pregnancy, lactation. |
Adverse Reactions |
Ototoxicity, nephrotoxicity, neurotoxicity (peripheral neuropathy, confusion, lethargy, hallucination, convulsion and mental depression, occasional respiratory depression), rarely hypersensitivity reaction. Potentially Fatal: Acute renal failure especially in combination with other nephrotoxic drugs. |
Drug Interactions |
Plasma levels increased by indometacin. Antihistamines (H1-receptor blocker) may mask early signs of ototoxicity. Incompatible with some β-lactam antibiotics. Potentially Fatal: Potentiates nephrotoxicity produced by other nephrotoxic drugs including other aminoglycosides, vancomycin and some cephalosporins. Potentiates ototoxicity produced by other aminoglycosides, ethacrynic acid. Ototoxicity potentiated by furosemide. See Below for More sisomicin Drug Interactions |
Mechanism of Actions |
Sisomicin binds to 30s and 50s ribosomal subunits of susceptible bacteria disrupting protein synthesis, thus rendering the bacterial cell membrane defective. |
ATC Classification |
J01GB08 - sisomicin ; Belongs to the class of other aminoglycosides. Used in the systemic treatment of infections. |
Available As |
|
Sisomycin
Post Review about Sisomycin Click here to cancel reply.
Sisomycin Containing Brands
Sisomycin is used in following diseases
Drug - Drug Interactions of Sisomycin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.